# ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE
> **ANDA074654** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 1996-12-31
## Drug
- **FDA Application Number:** ANDA074654
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE
- **Generic name:** Aspirin
- **Active ingredients:** ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SANDOZ
- **First approval:** 1996-12-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074654)
---
*MORVS · CC0 1.0*